Boston, MA (PRWEB) September 04, 2014
Corista, the leader in the emerging market for digital pathology workflow management, today announced that Raphael Wechsler has joined the company as Chief Financial Officer.
“Mr. Wechsler is filling a key role in the management team as we expand both in size and market reach,” said Elizabeth Wingard, Corista’s Chief Executive Officer. “His experience in the capital markets and internationally will provide Corista with the financial leadership we need. He also brings a personal passion for improving our healthcare system and we’re excited to have him join us as we work with pathologists in support of their push to revolutionize the practice of pathology.”
“Corista is in a fantastic position to dramatically improve the speed and quality of pathology care,” said Raphael Wechsler. “I’m excited to contribute my skills and perspective to position Corista for this new phase in the company’s development.”
Mr. Wechsler brings over 20 years of financial management experience. He began his career at Fechtor Detwiler in 1990 where he rose to Senior Vice President. He then served at Morgan Stanley’s Boston office, as a Sr. VP, growing and managing a $100+ million portfolio and participating in over 100 public equity deals. Mr. Wechsler also served as the Executive Director of International Equities and Fund Manager at Glitnir Bank in Iceland during a critical time in the country’s financial crisis. In that role, Mr. Wechsler led the Global Equities Fund to outperform the benchmark by 700 basis points ahead of schedule with 1,200 basis point improvement/turnaround. He later rejoined Detwiler Fenton as their Chief Investment Officer; leading over 50 Capital Strategy pieces for both institutional and retail clients.
Mr. Wechsler holds a BA in Liberal Arts from Boston University and earned his MBA in Multi-National Finance & Strategy from the acclaimed IESE Business School in Barcelona, Spain.
Since 2004, Corista has been developing its image-based processing software and browser-based software platform. The platform, DP3, is a comprehensive solution for physicians in a digital environment. In 2014, Frost & Sullivan awarded Corista the New Product Innovation Award in Digital Pathology for its DP3 advancements.
DP3 provides physicians with a consolidated view of every patient case regardless of their point of origin or the WSI used to prepare the digital images. The integrated platform includes a comprehensive suite of workflow tools including the physician’s dashboard, image viewing, navigation, annotation, management, real time collaboration, and flexible reporting. DP3 integrates with existing Laboratory Information Systems, is hardware agnostic and supports a complete range of physician devices including high resolution monitors, tablets and touch screens.
For more information, please visit our website, or contact us at info(at)corista.com